What's new in paediatric sleep?

Brigitte Fauroux1

  • 1AP-HP, Hôpital Armand Trousseau, Pediatric Pulmonary Department, Université Pierre et Marie Curie-Paris 6, INSERM UMR-S 719, Paris, France. brigitte.fauroux@trs.aphp.fr <brigitte.fauroux@trs.aphp.fr>

Insights

New reference values for pediatric sleep reveal crucial developmental changes. Snoring and sleep-disordered breathing in children are linked to inflammation and autonomic dysfunction, potentially impacting adult cardiovascular health.

Area of Science:

  • Pediatric Sleep Medicine
  • Neurodevelopmental Pediatrics
  • Respiratory Medicine

Background:

  • Recent advances in understanding pediatric sleep include reference values for children aged 3.2-8.6 years.
  • These data highlight developmental changes related to central nervous system maturation during childhood sleep.
  • Snoring in infants shows a negative correlation with development, suggesting it is not always benign.

Purpose of the Study:

  • To investigate the link between obstructive sleep apnea (OSA) and airway inflammation in children.
  • To explore the role of leukotrienes (LT) in OSA-associated inflammation.
  • To assess autonomic nervous system function in children with sleep-disordered breathing (SDB).

Main Methods:

  • Analysis of reference values for pediatric sleep.
  • Measurement of leukotriene receptor expression and concentrations in adenotonsillar tissues.
  • Use of peripheral arterial tonometry to assess sympathetic tone in children with SDB.

Main Results:

  • Children with OSA exhibit higher expression of leukotriene (LT) 1 and 2 receptors and increased LT concentrations in adenotonsillar tissues compared to controls.
  • Treatment with montelukast, an LT receptor antagonist, shows efficacy in OSA management.
  • Persistent waking-associated autonomic nervous system dysfunction is observed in young children with SDB.

Conclusions:

  • Obstructive sleep apnea (OSA) in children is associated with significant airway inflammation mediated by leukotrienes.
  • Sleep-disordered breathing (SDB) in childhood may be an early indicator of cardiovascular risk in adulthood.
  • Autonomic nervous system dysfunction is a key finding in children with SDB.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares often...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Understanding Sleep01:11

Understanding Sleep

Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...